Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q3 2024 Earnings Conference Call November 13, 2024 8:00 AM ET
Company Participants
Robert Shawah - Co-Founder & CFO
David Luci - Co-Founder, President, CEO, Corporate Secretary & Director
Conference Call Participants
Thomas Yip - H.C. Wainwright
John Stinson - Private Investor
Operator
Greetings, and welcome to the Acurx Pharmaceuticals, Inc. Third Quarter 2024 Results and Business Update Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Robert Shawah, Chief Financial Officer. Thank you. You may begin.
Robert Shawah
Thank you. Good morning, and welcome to our call. This morning, we issued a press release providing financial results and company highlights for the third quarter of 2024, which is available on our website at acurxpharma.com.
Joining me today is Dave Luci, President and CEO of Acurx, who will give a corporate update and outlook. After that, I'll provide some highlights of the financials for the quarter ended September 30, 2024, and then turn the call back over to Dave for his closing remarks.
As a reminder, during today's call, we'll be making certain forward-looking statements. These forward-looking statements are based on current information, assumptions, estimates and projections about future events, that are subject to change and involve a number of risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements.
Investors should consider these risks and other information described in our filings made with the Securities and Exchange Commission, including our quarterly report on Form 10-Q, which we filed on Tuesday, November 12, 2024.
We request not to place undue reliance on these forward-looking statements, and Acurx disclaims any obligation to update such statements at any time in the future. This conference call contains time-sensitive information that's accurate
- Read more current ACXP analysis and news
- View all earnings call transcripts